Dr. Jeffrey A. Kittel
Claim this profileAurora BayCare Medical Center
Studies Cancer
Studies Tumors
8 reported clinical trials
29 drugs studied
Area of expertise
1Cancer
p16 positive
Stage I
Stage II
2Tumors
Stage IV
Affiliated Hospitals
Clinical Trials Jeffrey A. Kittel is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
More about Jeffrey A. Kittel
Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jeffrey A. Kittel has experience with
- Cisplatin
- Stereotactic Body Radiation Therapy
- Intensity-Modulated Radiation Therapy
- Nivolumab
- Image Guided Radiation Therapy
- Degarelix
Breakdown of trials Jeffrey A. Kittel has run
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey A. Kittel specialize in?
Jeffrey A. Kittel focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved p16 positive patients, or patients who are Stage I.
Is Jeffrey A. Kittel currently recruiting for clinical trials?
Yes, Jeffrey A. Kittel is currently recruiting for 4 clinical trials in Green Bay Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey A. Kittel has studied deeply?
Yes, Jeffrey A. Kittel has studied treatments such as Cisplatin, Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Jeffrey A. Kittel?
Apply for one of the trials that Jeffrey A. Kittel is conducting.
What is the office address of Jeffrey A. Kittel?
The office of Jeffrey A. Kittel is located at: Aurora BayCare Medical Center, Green Bay, Wisconsin 54311 United States. This is the address for their practice at the Aurora BayCare Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.